company background image
CHE logo

Chemed NYSE:CHE Voorraadrapport

Laatste prijs

US$525.03

Marktkapitalisatie

US$7.9b

7D

-13.8%

1Y

-9.9%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Chemed Corporation

NYSE:CHE Voorraadrapport

Marktkapitalisatie: US$7.9b

CHE Overzicht aandelen

Chemed Corporation biedt hospice- en palliatieve zorgdiensten aan patiënten via een netwerk van artsen, gediplomeerde verpleegkundigen, thuiszorgassistenten, maatschappelijk werkers, geestelijken en vrijwilligers, voornamelijk in de Verenigde Staten.

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$685.00
FV
23.4% undervalued intrinsic discount
7.20%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative

Chemed Corporation Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Chemed
Historische aandelenkoersen
Huidige aandelenkoersUS$525.03
52 Week HoogtepuntUS$654.62
52 Week LaagUS$523.33
Bèta0.44
11 maand verandering-9.72%
3 maanden verandering-8.81%
1 Jaar Verandering-9.86%
33 jaar verandering4.80%
5 jaar verandering29.37%
Verandering sinds IPO4,541.15%

Recent nieuws en updates

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Recent updates

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Rendement voor aandeelhouders

CHEUS HealthcareUS Markt
7D-13.8%-1.1%-1.9%
1Y-9.9%0.7%30.4%

Rendement versus industrie: CHE presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 0.7 % opleverde.

Rendement versus markt: CHE presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.4 % opleverde.

Prijsvolatiliteit

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement4.2%
Healthcare Industry Average Movement6.7%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: CHE heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van CHE is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
197015,087Kevin McNamarawww.chemed.com

Chemed Corporation biedt hospice- en palliatieve zorgdiensten aan patiënten via een netwerk van artsen, geregistreerde verpleegkundigen, thuiszorgassistenten, maatschappelijk werkers, geestelijken en vrijwilligers, voornamelijk in de Verenigde Staten. Het bedrijf is actief in de segmenten VITAS en Roto-Rooter. Het bedrijf biedt loodgieterswerk, afvoerreiniging, uitgraving, waterherstel en andere aanverwante diensten aan particuliere en commerciële klanten via eigen vestigingen, onafhankelijke aannemers en franchisenemers.

Chemed Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Chemed zich tot de beurswaarde?
CHE fundamentele statistieken
MarktkapitalisatieUS$7.94b
Inkomsten(TTM)US$301.73m
Inkomsten(TTM)US$2.38b

26.0x

Koers/Winstverhouding

3.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
CHE resultatenrekening (TTM)
InkomstenUS$2.38b
Kosten van inkomstenUS$1.53b
BrutowinstUS$847.80m
Overige uitgavenUS$546.06m
InkomstenUS$301.73m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)20.21
Brutomarge35.66%
Nettowinstmarge12.69%
Schuld/Eigen Vermogen Verhouding0%

Hoe presteerde CHE op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.4%

Huidig dividendrendement

8%

Uitbetalingsratio